EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy

Andrew B Mendlowitz iD, Jennifer A Flemming, Tatyana Kushner iD, William W L Wong, Zoë R Greenwald iD, Wenbin Li, Bo Chen, Jeffrey C Kwong iD, Chelsea Masterman, Camelia Capraru, Jordan J Feld iD, Mia J Biondi

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Andrew B Mendlowitz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Toronto Centre for Liver Disease/Viral Hepatitis Care Network (VIRCAN), University Health Network, Toronto, Canada. Hauptthemen laut MEDLINE: Pregnancy Complications, Infectious, Hepatitis C, Prenatal Care, Postnatal Care. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ICES, Ontario Ministry of Health, Ministry of Long-Term Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis C virus (HCV) infections have increased among younger populations, including pregnant people. While universal screening guidelines have improved case-finding, studies suggest low postpartum linkage-to-care rates. Better understanding of the peripartum HCV care cascade at the population level is needed to inform optimal management, including the role of treatment in pregnancy.

Methods

A retrospective cohort study linking pregnant individuals with HCV test records to health administrative data in Ontario, Canada. We examined the HCV care continuum, including during subsequent pregnancies. We used Andersen-Gill models to examine predictors of missed opportunities for treatment, defined as pregnancies occurring before/in absence of treatment, and initiating treatment.

Results

From 2003 to 2021, we identified 42 797 pregnancies in 16 888 people who tested HCV antibody-positive between 1999 and 2021. Of antibody-positive individuals, 14 538 (86.1%) had RNA testing and 7457 (51.3%) tested RNA-positive. Treatment uptake was 1.1%, 2.5%, and 5.2% at 1, 2, and 5 years after RNA positivity. Ultimately, 3861 (51.8%) initiated treatment and 2277 (30.5%) demonstrated sustained virologic response. Among those with confirmed chronic HCV, 47.5% (n = 3025) experienced a missed opportunity for treatment, with 19.2% (n = 1221) having multiple missed opportunities. Numbers of pregnancies and diagnosis year pre-2012 were associated with higher likelihood of a missed opportunity for treatment, while diagnoses of substance use disorder, HIV, and chronic disease were associated with lower likelihood.

Conclusions

Despite diagnosis, <10% initiated treatment within 5 years of RNA positivity and multiple pregnancies occurred before treatment, resulting in repeated exposures. Additional efforts will be required to ensure linkage-to-care and treatment either during pregnancy or postpartum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy Complications, InfectiousHepatitis CPrenatal CarePostnatal CareHumansFemalePregnancyRetrospective StudiesAdultOntarioAntiviral AgentsYoung AdultHepacivirusPostpartum Period

Stichwörter der Autor:innen

health administrative datalinkage to carepregnancyvertical transmissionviral hepatitis

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Toronto Centre for Liver Disease/Viral Hepatitis Care Network (VIRCAN), University Health Network, Toronto, Canada.
  • ICES, Queen's University, Kingston, Canada.
  • Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Canada.
  • School of Health Policy & Management, York University, Toronto, Canada.
  • Department of Medicine, Queen's University, Kingston, Canada.
  • Department of Public Health Sciences, Queen's University, Kingston, Canada.

ORCID-Profile: Andrew B Mendlowitz, Tatyana Kushner, Zoë R Greenwald, Jeffrey C Kwong, Jordan J Feld

Förderung

  • ICES
  • Ontario Ministry of Health
  • Ministry of Long-Term Care
  • CIHR
  • NIH HHS
  • Canadian Network on Hepatitis C
  • Public Health Agency of Canada
  • NHLBI NIH HHS

Zitieren

APA

Mendlowitz, A. B., Flemming, J. A., Kushner, T., Wong, W. W. L., Greenwald, Z. R., Li, W., Chen, B., Kwong, J. C., Masterman, C., Capraru, C., Feld, J. J., & Biondi, M. J. (2026). Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf578

Vancouver

Mendlowitz AB, Flemming JA, Kushner T, Wong WWL, Greenwald ZR, Li W, et al. Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf578

BibTeX
@article{Mendlowitz2026,
  author = {Mendlowitz, Andrew B and Flemming, Jennifer A and Kushner, Tatyana and Wong, William W L and Greenwald, Zoë R and Li, Wenbin and Chen, Bo and Kwong, Jeffrey C and Masterman, Chelsea and Capraru, Camelia and Feld, Jordan J and Biondi, Mia J},
  title = {Gaps in the Hepatitis C Prenatal and Postpartum Care Cascade: Rationale for Treatment in Pregnancy},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf578}
}
Kostenlos starten →